Analyses of airborne particulates and human urine by inductively coupled plasma-atomic emission spectrometry /

October 1978.

A study of plasma stability in microwave cavities by a frequency-shift analog.

"Prepared for the Air Force Ballistic Missile Division, Headquarters Air Research and Development Command, under contract AF 04 (647)-309, Thermonuclear Propulsion Research."

Dynamic stabilization of a plasma column.

"This report was prepared in connection with Space Technology Laboratories Program of General Research."

Plasma studies in a shock tube,

"This work was supported by the Air Research and Development Center, Griffis Air Force Base, New York."

Plasma turbulence.

"Prepared for the United States Atomic Energy Commission, under AEC Contract AT (04-3)-321, Plasma Turbulence Research."

Space charge limited current flow from a plane, plasma cathode,

"Prepared for the Air Force Ballistic Missile Division, Headquarters Air Research and Development Command, under contract AF 04(647)-309, Thermonuclear Propulsion Research."

Radiation by plasma oscillations in a bounded plasma in a magnetic field.

At head of title: PRL-9-23.

The analytical description of a multicomponent plasma in high-frequency fields. Contract no. AF 30(602)-2077.

"RADC TN 61-150.

The use of low impedance transmission lines in plasma heating and confinement studies,

"Prepared for the Air Force Ballistic Missile Division, Headquarters Air Research and Development Command, under Contract AF 04(647)-309, Thermonuclear Propulsion Research."

Magnetic plasma propulsion by means of a travelling sinusoidal field.

"STL/TR-60-0000-09114."

Experimental investigation of plasma micro-instabilities in crossed magnetic and AC electric fields. Contract no. AF19(628)-5832, Project no. 5635, Task no. 563504, Work Unit no. 56350401.

"AFCRL-68-0044."

The magnetic induction plasma engine.

Mode of access: Internet.

The measurement of nicotine in human plasma by high-performance liquid chromatography-electrospray-tandem mass spectrometry

The authors describe a reverse-phase high-performance liquid chromatography-electrospray-tandem mass spectrometry method for the measurement of nicotine in human plasma. Samples (500 muL) with added deuterium-labeled d(3)-nicotine as an internal standard (IS) were treated with a 2-step process of ether extraction (6 mL) followed by back-extraction into 0.1% formic acid (50 muL). Chromatography was performed on a phenyl Novapak column with a mobile phase consisting of 50% 10 mM ammonium fortriate (pH 3.3) and acetonitrile (50:50, vol/vol). A flow rate of 0.2 mL/min resulted in a total analysis time of 5 minutes per sample. Mass spectrometric detection was by selected reactant monitoring (nicotine m/z 163.2 --> 130.2; IS m/z 166.2 --> 87.2). The assay was linear from 0.5 to 100 mug/L (r > 0.993, n = 9). The accuracy and imprecision of the method for quality control sampleswere 87.5% to 113% and < 10.2%, respectively. Interday accuracy and imprecision at the limit of quantification (0.5 mug/L) was 113% and 7.2% (n = 4). The process efficiency for nicotine in plasma was > 75%. The method described has good process efficiency, stabilized nicotine, avoided concentration steps, and most importantly minimized potential contamination. Further, we have established that water-based standards and controls are interchangeable with plasma-based samples. This method was used successfully to measure the pharmacokinetic profiles of subjects involved in the development of an aerosol inhalation drug delivery system.

Misleading high tobramycin plasma concentrations can be caused by skin contamination of fingerprick blood following inhalation of nebulized tobramycin (TOBI (R)) - A short report

We observed unexpected high plasma concentrations of tobrarriycin (48.5 and 28.1 mg/L) in fingerprick blood samples after the nebulization of tobramycin solution for inhalation (tobramycin 300 mg/5 mL, TOBI(R)) by 2 young children aged 3 years. To investigate whether dermal contamination could be the source of error, 3 adult volunteers were present during another nebulization by a third child (age 2 years). The volunteers had exposure to tobramycin by handling the nebulizer or the nebule and also by inhalation from holding the child and being in close proximity while TOBI(R) was being administered. Five blood samples by fingerprick and 2 by venipuncture were collected and assayed for tobramycin concentration. On each occasion the site was swabbed with alcohol wipes to mimic standard patient sampling methods. One site was resampled after cleaning of hands with 2% chlorhexidine gluconate and water. Tobramycin concentrations from venipuncture 1-2 hours after nebulization were all < 0.2 mg/L except for 1 result of 1.2 mg/L. The tobramycin concentrations from fingerpricks before hand washing varied between 6.8 and 172 mg/L, and after hand washing between 0.3 and 17.6 mg/L. Contamination of fingers with tobramycin is likely to have caused the error in the 2 initial cases and did cause misleadingly elevated levels in the adult volunteers. We caution that therapeutic drug monitoring of nebulized tobramycin should not be done by fingerprick sampling, and care should be taken to avoid contamination of the venipuncture site.